Reducing plasma HIV RNA improves muscle amino acid metabolism

American Journal of Physiology. Endocrinology and Metabolism
Kevin E YarasheskiWilliam G Powderly

Abstract

We reported (Yarasheski KE, Zachwieja JJ, Gischler J, Crowley J, Horgan MM, and Powderly WG. Am J Physiol Endocrinol Metab 275: E577-E583, 1998) that AIDS muscle wasting was associated with an inappropriately low rate of muscle protein synthesis and an elevated glutamine rate of appearance (Ra Gln). We hypothesized that high plasma HIV RNA caused dysregulation of muscle amino acid metabolism. We determined whether a reduction in HIV RNA (> or =1 log) increased muscle protein synthesis rate and reduced R(a) Gln and muscle proteasome activity in 10 men and 1 woman (22-57 yr, 60-108 kg, 17-33 kg muscle) with advanced HIV (CD4 = 0-311 cells/microl; HIV RNA = 10-375 x 10(3) copies/ml). We utilized stable isotope tracer methodologies ([13C]Leu and [15N]Gln) to measure the fractional rate of mixed muscle protein synthesis and plasma Ra Gln in these subjects before and 4 mo after initiating their first or a salvage antiretroviral therapy regimen. After treatment, median CD4 increased (98 vs. 139 cells/microl, P = 0.009) and median HIV RNA was reduced (155,828 vs. 100 copies/ml, P = 0.003). Mixed muscle protein synthesis rate increased (0.062 +/- 0.005 vs. 0.078 +/- 0.006%/h, P = 0.01), Ra Gln decreased (387 +/- 33 vs. 323 +/- 15 microm...Continue Reading

References

Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P W WattM J Rennie
Jul 1, 1986·The American Journal of Physiology·D DarmaunD M Bier
May 15, 1985·Analytical Biochemistry·D DarmaunD E Matthews
May 1, 1980·The American Journal of Physiology·D E MatthewsD M Bier
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y RefaeliD B Weiner
Jan 1, 1995·The Journal of Clinical Investigation·N NurjhanJ E Gerich
Feb 1, 1995·The American Journal of Physiology·K E YarasheskiD M Bier
Aug 1, 1994·The American Journal of Physiology·P Q BaumannK S Nair
Jun 1, 1996·The American Journal of Clinical Nutrition·Z M WangS B Heymsfield
May 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·K MulliganM Schambelan
Oct 1, 1998·The American Journal of Physiology·K E YarasheskiW G Powderly
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·P AndréV Lotteau
Dec 17, 1998·International Journal of Molecular Medicine·M LloveraJ M Argiles
Jul 17, 1999·The American Journal of Physiology·K E YarasheskiD R Sinacore
Nov 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·P Balagopal
Apr 6, 2000·American Journal of Physiology. Endocrinology and Metabolism·D L HastenK E Yarasheski
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A WankeS L Gorbach
Oct 31, 2001·The American Journal of Clinical Nutrition·A Y McDermottS Gorbach
Apr 3, 2002·Nature Medicine·Anthony D KelleherDavid A Price
Apr 20, 2002·AIDS·Marco PiccininiPier-Angelo Tovo
Mar 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Steven GrinspoonUNKNOWN Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss
Oct 30, 2003·HIV Clinical Trials·Fatma G Huffman, Melanie E Walgren
Mar 25, 2004·The American Journal of Pathology·Angélique HeckmannYves Sagot

❮ Previous
Next ❯

Citations

Mar 27, 2007·Journal of the American Society for Mass Spectrometry·Randall J BatemanKevin E Yarasheski
Jun 27, 2006·Nature Medicine·Randall J BatemanDavid M Holtzman
Jan 18, 2013·International Journal of Sports Medicine·E L KullmanJ P Kirwan
Feb 12, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Kevin E YarasheskiUNKNOWN Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)
Aug 21, 2008·American Journal of Physiology. Endocrinology and Metabolism·Anne M PruznakCharles H Lang
Apr 29, 2008·AIDS Research and Therapy·Jeffrey S OtisDavid M Guidot
Aug 19, 2011·AIDS Research and Therapy·Caroline R ClaryJeffrey S Otis
Sep 28, 2006·Diabetes·Dominic N ReedsKevin E Yarasheski
Mar 7, 2009·Medicina clínica·Oscar Moreno-PérezJoaquín Portilla
Oct 24, 2007·Metabolism: Clinical and Experimental·Rajasekhar Ramakrishnan
Oct 19, 2007·Clinical Trials : Journal of the Society for Clinical Trials·E Todd SchroederStanley P Azen
Oct 27, 2005·American Journal of Physiology. Endocrinology and Metabolism·Magali Prod'hommeJean Grizard
Apr 9, 2011·Journal of Cachexia, Sarcopenia and Muscle·Fabian ChenGary A Herman
Jan 14, 2016·AIDS·Kristine M ErlandsonTodd T Brown
Jun 17, 2016·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Kaushik GhosalGary E Landreth
Jun 23, 2007·The Journal of Nutrition·Anna E Thalacker-MercerWayne W Campbell
May 7, 2021·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Luciano Rodrigo Lopes
Jan 30, 2007·Pharmacology & Therapeutics·Gordon S LynchJames G Ryall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved